Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2.
about
Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cellsCD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells.The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.Melatonin Rescues Mesenchymal Stem Cells from Senescence Induced by the Uremic Toxin p-Cresol via Inhibiting mTOR-Dependent Autophagy.HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression.HPV16 E7 increases COX-2 expression and promotes the proliferation of breast cancer.
P2860
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Celecoxib inhibits proliferati ...... ion of β-catenin and mTORC1/2.
@en
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia
@nl
type
label
Celecoxib inhibits proliferati ...... ion of β-catenin and mTORC1/2.
@en
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia
@nl
prefLabel
Celecoxib inhibits proliferati ...... ion of β-catenin and mTORC1/2.
@en
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia
@nl
P2093
P2860
P356
P1433
P1476
Celecoxib inhibits proliferati ...... ion of β-catenin and mTORC1/2.
@en
P2093
Alberto Minassi
Armando A Genazzani
Beatrice Riva
Bruno Calabretta
Ilaria Gnemmi
Marco De Dominici
Paolo Salomoni
Pier Luigi Canonico
Samanta A Mariani
Valentina Minieri
P2860
P304
81555-81570
P356
10.18632/ONCOTARGET.13146
P407
P577
2016-11-07T00:00:00Z